Glutamatergic agents show promise for mood, anxiety disorders
Glutamergic agents may one day be used as a novel treatment for mood and anxiety disorders.
View full story
Post your comment.
Protein identified linked to most common movement disorder, essential tremor
Talking-therapy treatments to manage osteoarthritis pain
Inherited Alzheimer's damage greater decades before symptoms appear
Cigarette smoking may cause physical changes in brains of young smokers, study shows
Plant extract offers hope for infant motor neuron therapy
Cocaine, pleasure principle explored in new rat study
Learning how to listen with neurofeedback
Computers used to 'see' neurons to better understand brain function
Marijuana's anxiety relief effects: Receptors found in emotional hub of brain
Drug protects mice against malaria brain damage, raises levels of BDNF in humans